SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-183874
Filing Date
2023-07-07
Accepted
2023-07-07 17:06:28
Documents
3
Group Members
FORBION GROWTH MANAGEMENT B.V.FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF U.A.FORBION GROWTH OPPORTUNITIES FUND II COOPERATIEF U.A.FORBION II MANAGEMENT B.V.FORBION INTERNATIONAL MANAGEMENT B.V.FORBION IV MANAGEMENT B.V.FORGROWTH NAP B.V.STICHTING ADM

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d508282dsc13da.htm SC 13D/A 157297
2 EX-99.5 d508282dex995.htm EX-99.5 14466
3 EX-99.6 d508282dex996.htm EX-99.6 33299
  Complete submission text file 0001193125-23-183874.txt   207021
Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 356993000
Forbion Capital Fund IV Cooperatief U.A. (Filed by) CIK: 0001823747 (see all company filings)

IRS No.: 981445896 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93833 | Film No.: 231077556
SIC: 2834 Pharmaceutical Preparations